Iron Deficiency and Anemia
We recommend
Iron Deficiency and Administration of Ferric Carboxymaltose in Patients with Heart Failure
Iron deficiency is very common in patients with heart failure and is associated with exercise intolerance, reduced quality of life, increased mortality, and higher risk of hospitalization, regardless of the presence of anemia. Clinical studies have previously demonstrated the positive effect of intravenous administration of ferric carboxymaltose (FCM) in patients with chronic heart failure with reduced ejection fraction of the left ventricle. The AFFIRM-AHF study investigated the effect of FCM administration initiated shortly before…
Effect of Administering Ferric Carboxymaltose on Quality of Life in Heart Failure Patients
The quality of life in patients with heart failure is significantly reduced. The concurrent…
Importance of Testing for Iron Deficiency in Patients with Chronic Heart Failure and Treatment Options
Intravenous iron application in patients with heart failure and iron deficiency is now part of ESC…
No content is currently available on this topic.
Subscribe
Conferences news
Go to records
Most read on this topic
Journal on this topic
Related topic
Conferences news
Go to records
Most read on this topic
- Iron Deficiency and Administration of Ferric Carboxymaltose in Patients with Heart Failure
- Importance of Testing for Iron Deficiency in Patients with Chronic Heart Failure and Treatment Options
- Effect of Administering Ferric Carboxymaltose on Quality of Life in Heart Failure Patients
Journal on this topic
Related topic